Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy

NCT01498822 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Levetiracetam
DRUG: Oxcarbazepine

Sponsor

Korea UCB Co., Ltd.